"Patient Preference" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Individual's expression of desirability or value of one course of action, outcome, or selection in contrast to others.
| Descriptor ID |
D057240
|
| MeSH Number(s) |
F01.100.150.750.625.500 F01.145.488.887.625.500 N04.452.822.700.500 N05.300.150.800.625.500
|
| Concept/Terms |
Patient Preference- Patient Preference
- Patient Preferences
- Preference, Patient
- Preferences, Patient
|
Below are MeSH descriptors whose meaning is more general than "Patient Preference".
Below are MeSH descriptors whose meaning is more specific than "Patient Preference".
This graph shows the total number of publications written about "Patient Preference" by people in this website by year, and whether "Patient Preference" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 0 | 2 |
| 2013 | 3 | 1 | 4 |
| 2014 | 3 | 0 | 3 |
| 2016 | 4 | 2 | 6 |
| 2017 | 4 | 1 | 5 |
| 2018 | 2 | 4 | 6 |
| 2019 | 1 | 2 | 3 |
| 2020 | 2 | 0 | 2 |
| 2021 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Patient Preference" by people in Profiles.
-
Wong ND, Bang M, Block RC, Peterson ALH, Karalis DG. Perceptions and Barriers on the Use of Proprotein Subtilisin/Kexin Type 9 Inhibitors in Heterozygous Familial Hypercholesterolemia (From a Survey of Primary Care Physicians and Cardiologists). Am J Cardiol. 2021 08 01; 152:57-62.
-
Jazieh AR, Abuelgasim KA, Ardah HI, Alkaiyat M, Da'ar OB. The trends of complementary alternative medicine use among cancer patients. BMC Complement Med Ther. 2021 Jun 08; 21(1):167.
-
Hollin IL, Janssen E, Kelley MA, Bridges JFP. Do people have differing motivations for participating in a stated-preference study? Results from a latent-class analysis. BMC Med Inform Decis Mak. 2021 02 06; 21(1):44.
-
Hakim H, Newland P, Oliver BJ. Initial User Testing of Decision Aids for Multiple Sclerosis Disease-Modifying Therapies. J Neurosci Nurs. 2020 Aug; 52(4):160-165.
-
Kane LT, Thakar O, Jamgochian G, Lazarus MD, Abboud JA, Namdari S, Horneff JG. The role of telehealth as a platform for postoperative visits following rotator cuff repair: a prospective, randomized controlled trial. J Shoulder Elbow Surg. 2020 Apr; 29(4):775-783.
-
Minneci PC, Hade EM, Lawrence AE, Saito JM, Mak GZ, Hirschl RB, Gadepalli S, Helmrath MA, Leys CM, Sato TT, Lal DR, Landman MP, Kabre R, Fallat ME, Fischer BA, Cooper JN, Deans KJ. Multi-institutional trial of non-operative management and surgery for uncomplicated appendicitis in children: Design and rationale. Contemp Clin Trials. 2019 08; 83:10-17.
-
Mansfield C, Gebben DJ, Sutphin J, Tepper SJ, Schwedt TJ, Sapra S, Shah N. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment. Headache. 2019 05; 59(5):715-726.
-
Kadakia KC, Kidwell KM, Barton DL, Schott AF, Hayes DF, Griggs JJ, Henry NL. Factors influencing the use of extended adjuvant endocrine therapy. Breast Cancer Res Treat. 2019 May; 175(1):181-189.
-
Rocque G, Miller-Sonnet E, Balch A, Stricker C, Seidman J, Stiles S, Ruggerio J, Paynter N, Lewis M, Kamal A. Engaging Multidisciplinary Stakeholders to Drive Shared Decision-Making in Oncology. J Palliat Care. 2019 Jan; 34(1):29-31.
-
Reyes J, Washio Y, Stringer M, Teitelman AM. Usability and Acceptability of Everhealthier Women, a Mobile Application to Enhance Informed Health Choices. J Obstet Gynecol Neonatal Nurs. 2018 11; 47(6):853-861.